Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name INCB054329
Trade Name
Synonyms INCB-054329
Drug Descriptions

INCB054329 is BET inhibitor, which results in decreased expression of BET protein-regulated genes including MYC, potentially leading to decreased tumor cell proliferation (PMID: 30206163)

DrugClasses BET Inhibitor (Pan) 32
CAS Registry Number 1628607-64-6
NCIT ID C121948

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AZD1208 + INCB054329 AZD1208 INCB054329 0 0
INCB053914 + INCB054329 INCB053914 INCB054329 0 0
INCB054329 INCB054329 0 1
INCB054329 + INCB059872 INCB054329 INCB059872 0 0
INCB054329 + Itacitinib INCB054329 Itacitinib 0 0
INCB054329 + Pemigatinib INCB054329 Pemigatinib 0 0
INCB054329 + Ruxolitinib INCB054329 Ruxolitinib 0 0
INCB054329 + SGI-1776 INCB054329 SGI-1776 0 0


Additional content available in CKB BOOST